(Q41510588)

1 October 2017

1 reference

title

Psychopharmacologic treatment of pathologic aggression (English)

1 reference

1 October 2017

Fava M

1

1 reference

1 October 2017

publication date

1 June 1997

1 reference

Psychiatric Clinics of North America

1 October 2017

published in

1 reference

1 October 2017

volume

20

1 reference

1 October 2017

issue

2

1 reference

1 October 2017

page(s)

427-451

1 reference

Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients.

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A controlled trial of phenytoin in impulsive aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Conduct and Oppositional Disorder in Clinically Referred Children With Attention Deficit Disorder: A Controlled Family Study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Midazolam for aggressivity and violence in three mentally retarded patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

An inventory for assessing different kinds of hostility.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Factors associated with inpatient and outpatient treatment for children and adolescents with serious mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Cannabis, catecholamines, rapid eye movement sleep and aggressive behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Aggression in the demented patient: a double-blind study of loxapine versus haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Haloperidol for sedation of disruptive emergency patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Fluoxetine and impulsive aggressive behavior in personality-disordered subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Pattern of use of antidepressants in long-term care facilities for the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Treatment of young delinquent boys with diphenylhydantoin sodium and methyphenidate. A controlled comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Treatment of posttraumatic stress disorder with amitriptyline and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Overview: efficacy and safety of the rapid neuroleptization method with injectable haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Neurochemical and psychopharmacologic aspects of aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Comparison of SCH-12679 and thioridazine in aggressive mental retardates.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Are thymoleptic-responsive "anger attacks" a discrete clinical syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Fluoxetine treatment of anger attacks: a replication study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Lithium for irritability in post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Efficacy of carbamazepine in assaultive patients with frontal lobe dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Brain serotonin metabolism in isolated aggressive mice

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Treatment of behavioral problems with pindolol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Carbamazepine in treatment of violent schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION: A NEW SCALE FOR MEASURING IMPROVEMENT IN CHRONIC SCHIZOPHRENIA

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Clonidine treatment of hyperactive and impulsive children with autistic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Risperidone for treating dementia-associated aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Effects of methylphenidate on adolescents with aggressive conduct disorder and ADDH: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Treatment of aggressive children with clonidine: results of an open pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The Suicide and Aggression Survey: a semistructured instrument for the measurement of suicidality and aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Effects of diphenylhydantoin on disruptive behavior. Study of male delinquents.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Epilepsy and violence: evidence for a neuropsychotic-aggressive syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Diphenylhydantoin in Children With Severe Temper Tantrums

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Outcome in bipolar affective disorder after stereotactic tractotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Carbamazepine for the violent psychiatric patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Pipothiazine palmitate in the management of aggressive mentally handicapped patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Fluoxetine in the treatment of borderline and schizotypal personality disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Sodium valproate in the treatment of behavioral disturbance in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Carbamazepine in the psychiatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Zuclopenthixol, melperone and haloperidol/levomepromazine in the elderly. Meta-analysis of two double-blind trials at 15 nursing homes in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Staff observation aggression scale, SOAS: presentation and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Factor structure of the Barratt impulsiveness scale

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Effects of trazodone on aggressive behavior in seven patients with organic mental disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Sertraline in the treatment of severe aggressiveness in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The natural history of behavioural symptoms among severely and profoundly mentally retarded patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Anger management and temper control: critical components of posttraumatic stress disorder and substance abuse treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A controlled trial of desipramine in 18 men with posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Head injury and marital aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The effect of lithium on impulsive aggressive behavior in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A controlled trial of phenelzine in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Neurotransmitters regulating feline aggressive behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Bupropion effects in attention deficit and conduct disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

A double-blind comparison of zuclopenthixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Nonneuroleptic treatment of disruptive behavior in organic mental syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Irritability: definition, assessment and associated factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Efficacy of phenelzine and haloperidol in borderline personality disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Measuring Intrafamily Conflict and Violence: The Conflict Tactics (CT) Scales

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Droperidol versus haloperidol for chemical restraint of agitated and combative patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Eltoprazine for aggression in schizophrenia and mental retardation.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The long-term use of lithium in aggressive prisoners.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Factors associated with a good response to lithium in aggressive mentally handicapped subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Disinhibitory reactions to benzodiazepines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Citalopram, a selective serotonin reuptake inhibitor, in the treatment of aggression in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Eltoprazine in mentally retarded self-injuring patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Tryptophan treatment of aggressive psychiatric inpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Divalproex sodium in the treatment of aggressive behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Cognitive and affective responses to lithium in patients with organic brain syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The development of an observer-scale for measuring social dysfunction and aggression.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Lithium in Non-Manic-Depressives: Antiaggressive Effect and Red Blood Cell Lithium Values

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Amitriptyline and methylphenidate treatment of behaviorally disordered children

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Paroxetine as a treatment for premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

Propranolol in the treatment of rage and violent behavior associated with Korsakoff's psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The Overt Aggression Scale for the objective rating of verbal and physical aggression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

The aggression questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970321-X

7 January 2021

10.1016/S0193-953X(05)70321-X

Identifiers

DOI

1 reference

1 October 2017

1 reference